Clinical trial
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00444613 · Eisai Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00444613 |
|---|---|
| Title | A Study in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| Official title | A Phase II/III Study in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| Lead sponsor | Eisai Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis (ALS) |
| Intervention type | Drug |
| Interventions | E0302 (mecobalamin), Placebo |
| Enrollment | 373 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Mar 8, 2007 |
| Last update posted | Jun 18, 2023 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: